Welcome to our dedicated page for Verisign SEC filings (Ticker: VRSN), a comprehensive resource for investors and traders seeking official regulatory documents including 10-K annual reports, 10-Q quarterly earnings, 8-K material events, and insider trading forms.
The VeriSign, Inc. (VRSN) SEC filings page on Stock Titan brings together the company’s regulatory disclosures, including Form 8‑K current reports and other registered offerings referenced in its communications. Verisign is a Delaware corporation listed on NASDAQ, and its filings identify it under Commission File Number 000-23593 and IRS Employer Identification Number 94-3221585.
Verisign uses Form 8‑K to report a variety of material events. Recent 8‑K filings include items on results of operations and financial condition, where the company furnishes earnings press releases for quarters ended June 30 and September 30, and clarifies that these materials are not deemed “filed” for certain Exchange Act purposes unless specifically incorporated by reference. Other 8‑K items address Board and executive matters, such as the appointment of a new director, director compensation and indemnity agreements, and the resignation of a long‑serving director, along with the Board’s intention to appoint a Lead Independent Director and adjust its size.
Verisign also files 8‑Ks under Item 8.01 Other Events to describe capital markets transactions and corporate actions. One filing details an underwriting agreement for a secondary offering of common stock by selling stockholders affiliated with Berkshire Hathaway Inc., noting that Verisign itself is not selling shares and will not receive proceeds. Another 8‑K describes additional authorization under the company’s share repurchase program, including the total repurchase authorization and the types of transactions through which repurchases may be executed.
For investors analyzing VRSN, this page provides near real‑time access to such 8‑K filings as they appear on EDGAR. Stock Titan’s tools can surface the key points in these documents, helping users quickly understand new earnings releases, Board changes, capital allocation decisions, and capital markets activities without reading every line of the underlying forms.
A shareholder of VRSN filed a Rule 144 notice to sell 4,000 shares of common stock through Morgan Stanley Smith Barney LLC, with an aggregate market value of $985,360. The filing notes that about 92,700,000 shares of this class were outstanding at the time, providing context for the planned sale. The 4,000 shares were acquired as restricted stock units from the issuer on 09/22/2016.
The document also lists recent sales under a Rule 10b5-1 trading plan for Demetrios James Bidzos, including, for example, 5,000 common shares sold on 01/13/2026 for gross proceeds of $1,240,994.20. Additional plan sales occurred across multiple dates in October, November, and December 2025 in blocks of 2,000 or 5,000 shares with disclosed gross proceeds.
A holder of VRSN common stock, identified as Thomas C. Indelicarto, has filed a notice under Rule 144 to sell 498 common shares through Morgan Stanley Smith Barney LLC on or about 01/13/2026 on the NASDAQ, with an aggregate market value of $123,859.24. The filing notes that 92,700,000 common shares were outstanding. The seller acquired 157 shares as performance shares on 02/15/2024 and 341 shares as restricted stock on 05/15/2024, both from the issuer.
Over the prior three months, the same holder reported several open-market sales of the issuer’s common stock, including 501 shares sold on 12/09/2025 for gross proceeds of $125,285.07 and 332 shares sold on 01/06/2026 for $79,955.56. By signing the notice, the seller represents that they do not know of any undisclosed material adverse information about the issuer’s current or prospective operations.
Verisign Inc. executive Thomas C. Indelicarto, EVP, General Counsel & Secretary, reported a small insider sale of common stock. On January 9, 2026, he sold 166 shares of Verisign common stock in an open market transaction coded "S" at a price of $250 per share. After this transaction, he directly beneficially owned 31,111.0161 shares of Verisign common stock.
Thomas C. Indelicarto filed a notice of proposed sale under Rule 144 to sell 166 shares of common stock through Morgan Stanley Smith Barney on NASDAQ, with an approximate sale date of 01/09/2026. The filing lists an aggregate market value of about $41,500 for this planned sale and notes that 92,700,000 common shares were outstanding at the time referenced.
The 166 shares to be sold were acquired as restricted stock from the issuer on 05/15/2024, with the same date shown for payment and the consideration described as not applicable, consistent with equity awards. Over the prior three months, the same seller completed several sales of common stock, including 501 shares on 12/09/2025 for $125,285.07, 501 shares on 12/02/2025 for $126,562.62, and other transactions ranging from 332 to 501 shares with gross proceeds between roughly $79,955.56 and $131,722.92.
VeriSign, Inc. executive Thomas C. Indelicarto, EVP, General Counsel & Secretary, reported an insider sale of company stock. On January 6, 2026, he sold 332 shares of VeriSign common stock at a price of $240.83 per share, as shown in the non-derivative securities table. After this transaction, he beneficially owned 31,277.0161 shares of VeriSign common stock, held directly.
VeriSign Inc. executive D. James Bidzos, who serves as Exec. Chairman, President and CEO and is also a director, reported multiple open-market sales of VeriSign common stock. The transactions took place on December 16–18, 2025, with individual sale lots ranging from 40 to 2,373 shares per trade.
Weighted average sale prices disclosed include $240.5487, $241.9918, $242.819, $243.5312, $244.5723, $245.2386, $244.145, $244.8968, $246.0645 and a single trade at $246.96 per share, each representing multiple underlying transactions within stated price ranges. After these sales, Bidzos directly beneficially owns 421,099.1378 shares of VeriSign common stock.
Verisign Inc. executive chairman, president and CEO D. James Bidzos reported multiple sales of Verisign common stock on December 9–11, 2025. The Form 4 lists several transactions coded as sales at weighted-average prices between $239.56 and $250.98 per share, with each price reflecting numerous trades within narrow ranges.
After these transactions, Bidzos directly beneficially owns 430,099.1378 shares of Verisign common stock. This amount includes 132.6549 dividend equivalent restricted stock units acquired on November 25, 2025 under the company’s Amended and Restated 2006 Equity Incentive Plan.
VeriSign, Inc. (VRSN) reported that long-time director Dr. Timothy Tomlinson, 75, has resigned from its Board of Directors for personal reasons related to his family and other business interests, effective November 21, 2025. The company highlighted his service since its founding in 1995, including leadership on the Audit Committee, which it credits with promoting a culture of compliance.
VeriSign stated that Dr. Tomlinson’s retirement did not result from any disagreement with the company on operations, policies, or practices. In connection with his retirement, the Board is expected to appoint a Lead Independent Director and decrease the overall size of the Board.
VeriSign, Inc. (VRSN) reported insider stock sales by its Executive Chairman, President, and CEO, D. James Bidzos. A Form 4 filing shows a series of open‑market sales of VeriSign common stock on November 18–20, 2025, totaling 9,000 shares. Individual trades ranged from 80 to 2,705 shares per transaction.
The reported weighted average sale prices ranged from about $244.47 to $251.33 per share, with detailed price ranges provided for each trade. After these transactions, Bidzos beneficially owned approximately 438,966.4829 shares of VeriSign common stock in direct form.
VeriSign, Inc. executive reports tax-related share disposition
VeriSign, Inc. officer Thomas C. Indelicarto, EVP, General Counsel & Secretary, reported multiple small dispositions of VeriSign common stock on 11/15/2025. The transactions were coded "F" and described as shares withheld or delivered to the company to pay tax liabilities triggered by the vesting of restricted stock units, which is exempt under Rule 16b-3. Following these tax-withholding transactions at a price of $252.88 per share, Indelicarto beneficially owned approximately 32,562.4112 shares of VeriSign common stock directly.